Virtu Financial’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Virtu Financial’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-61,730	Closed	-$631K	–	2399
2023 Q1	$631K	Buy	61,730 +26,433	+75%	+$268K	0.07%	289
2022 Q4	$356K	Buy	35,297 +23,748	+206%	+$236K	0.05%	410
2022 Q3	$114K	Buy	+11,549	New	+$113K	0.01%	1049

Virtu Financial's ORIA Position: Q2 2023 in Review

Virtu Financial sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 61,730 shares — an estimated $631K sold.

Virtu Financial first reported a position in ORIA in Q3 2022 and held it in 3 quarters. The position peaked at $631K in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Virtu Financial reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Virtu Financial sold 61,730 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $631K.
Virtu Financial first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2022 and held it in 3 quarters.
Virtu Financial's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $631K in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.